A study of ovarian tissue from 28 postmenopausal women found that the organ keeps changing at the molecular level for decades after menopause. Researchers at Northwestern University and the Buck Institute for Research on Aging analyzed 5,812 protein groups and reported the work in Aging Cell on Oct. 14, 2026. The women were between 50 and 75 years old.
The finding cuts against the picture of the ovary as an organ that simply goes quiet once eggs run out. Proteins tied to inflammation, immune activity and tissue turnover rose in older ovaries, and some proteins linked in earlier work to ovarian cancer were more abundant, with the strongest signal in women in their 60s.
Protein mapping of 28 ovaries
The paper, titled “The Human Ovary Exhibits Dynamic Molecular Remodeling in the Decades Post-Menopause,” used mass spectrometry to measure proteins in normal ovarian tissue, according to the EurekAlert release. Hundreds of proteins changed with age after menopause. Younger postmenopausal ovaries carried more proteins that maintain cell and tissue structure, while older ones carried more tied to inflammation, immune activity and tissue turnover. The largest differences appeared between women in their 50s and those 70 and older, and some patterns resembled those seen in cellular senescence, a state in which cells stop dividing.
The sample is one ovary from each of the 28 women, and the researchers compared women within a roughly 25-year postmenopausal range rather than across the whole lifespan. Tissue was normal and cancer-free.
That design shapes what can be concluded. Because each woman contributed one sample at one age, the comparison between decades reflects differences among individuals, so factors such as genetics, health history and reproductive history are mixed in with age. The release does not describe how those were handled, and the full paper was not available for this account, so the summary here rests on the university’s release and the Northwestern story. The central result, that the tissue is molecularly active and not inert for decades, does not depend on resolving those details.
The voices behind the work
Francesca Duncan, an associate professor of reproductive science in medicine at Northwestern’s Feinberg School of Medicine and co-corresponding author, said that in the ovary there is a point of no return with respect to fertility, “But that’s what makes this study very different.” Birgit Schilling, a professor and director of the Mass Spectrometry Center at the Buck Institute and the other co-corresponding author, said “The ovary is not just a reproductive organ,” and described the data as showing the ovary was not stagnant. Mark Watson, a Buck Institute staff scientist in Schilling’s lab, spearheaded the proteomics.
The Northwestern account of the study adds a line from Duncan that gives the work its larger stakes: she asked whether the ovary is the canary in the coal mine in women. The work builds on a 2016 Northwestern study in mice, led by Duncan, that established fibrosis and inflammation as hallmarks of the aging ovary.
The “third hit” and what it does not say
The most attention-grabbing claim is also the most carefully hedged. Duncan said the aging ovary is a potential third hit for ovarian cancer, the researchers’ phrase for a possible added contribution to cancer risk. The release is explicit that it is a hypothesis and not an established finding. All tissue appeared normal, so the cancer-related protein signal does not mean the ovaries were cancerous or precancerous.
The researchers also do not know whether the changes are beneficial or harmful. Duncan said they do not yet know whether there is ever a point in a woman’s life when this organ is no longer beneficial, and the findings do not answer whether healthy ovaries should be removed after menopause. With 28 women, the study is small, and a difference between 60-year-olds and 70-year-olds seen across different women is not the same as watching individual ovaries change over time.
Funding and the senescence effort
The work was funded by the National Institutes of Health Common Fund’s Senescence Network program, through grants NIA U54 AG075932 and NCI UH3 CA275681. That program, known as SenNet, seeks to map senescent cells, rare cells that have stopped dividing, across the body and across a lifetime, producing public atlases and tools that other researchers can use.
For readers who want the primary record, the paper is listed in Aging Cell under DOI 10.1111/acel.70714. Media contacts named in the release are Kristin Samuelson at Northwestern and Robin Snyder at the Buck Institute, and the release identifies Duncan as also holding an associate professor in residence position at the Buck Institute, which reflects how closely the two institutions worked on the proteomics.
The next questions are the ones the authors flag themselves: whether the remodeling helps or harms, and whether it contributes to cancer risk or to other conditions in older women.
This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.
More from Morning Overview
- The FBI told the rest of ShinyHunters to surrender after a 24-year-old was arrested
- Two passengers died at an Ohio toll plaza, and the NTSB now wants the cash lanes shut
- Long use of a common prostate pill is tied to a higher chance of glaucoma
- Ford is recalling 223,472 F-150 pickups because the fuel tank can leak or detach
